SEARCH

SEARCH BY CITATION

References

  • 1
    Janot C, Courouce A–M, Maniéz M. Antibodies to hepatitis C vims in French blood donors. Lancet 1989; 2: 796797.
  • 2
    Conry–Cantilena C, VanRaden M, Gibble J, Melpolder J, Shakil AO, Viladomiu L, Cheung L, et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996; 334: 16911696.
  • 3
    Roudot–Thoraval F, Pawlotsky J–M, Deforges L, Girrollet P–P, Dhu–meaux D. Anti–HCV seroprevalence in pregnant women in France. Gut 1993 (Suppl): S55S56.
  • 4
    Kiyosawa K, Tanaka E, Sodeyama T, Yoshizawa K, Yabu K, Furuta K, Imai H, et al. Transmission of hepatitis C in an isolated area in Japan: community–acquired infection. Gastroenterology 1994; 106: 15961602.
  • 5
    Koretz RL, Abbey H, Coleman E, Gitnick G. Non–A, non–B post–transfusion hepatitis. Looking back in the second decade. Ann Intern Med 1993; 119: 110115.
  • 6
    Tong MJ, El–Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion–associated hepatitis C. N Engl J Med 1995; 332: 14631466.
  • 7
    Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, Kitamura T, Nakanishi K, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993; 328: 17971801.
  • 8
    Saracco G, Rosina F, Abate ML, Chiandussi L, Gallo V, Cerutti E, Di Napoli A, et al. Long–term follow–up of patients with chronic hepatitis C treated with different doses of interferon–a2b. Hepatology 1993; 18: 13001305.
  • 9
    Craxi A, Di Marco V, Lo lacono O, Almasio P, Bruno R, Camma C, Volpes R, et al. Transfusion–associated chronic hepatitis C: alpha–n1 interferon for 6 vs. 12 months. J Hepatol 1996; 24: 539546.
  • 10
    Poynard T, Bedossa P, Chevallier M, Mathurin P, Lemonnier C, Trepo C, Couzigou P, et al. A comparison of three interferon alpha–2b regimens for the long–term treatment of chronic non–A, non–B hepatitis. N Engl J Med 1995; 332: 14571462.
  • 11
    Pawlotsky J–M, Roudot–Thoraval F, Bastie A, Darthuy F, Rémiré J, Mé–treau J–M, Zafrani ES, et al. Factors affecting treatment responses to interferon–a in chronic hepatitis C. J Infect Dis 1996; 174: 17.
  • 12
    Snedecor GW, Cochran WG. Sample surveys. In: SnedecorGW, Coch–ranWG, eds. Statistical methods. Ames: Iowa State University Press, 1989: 431456.
  • 13
    DixonWJ, BrownMB, EngelmanL, JennrichRI, eds. BMDP statistical software, Berkeley, CA: University of California, 1990.
  • 14
    Scheuer PJ, Ashrafzadeh P, Sherlock S, Brown D, Dusheiko GM. The pathology of hepatitis C. Hepatology 1992; 15: 567571.
  • 15
    Caselmann WH, Alt M. Hepatitis C virus infection as a major risk factor for hepatocellular carcinoma. J Hepatol 1996; 24 (suppl 2): 6166.
  • 16
    Gordon SC, Elloway RS, Long JC, Dmuchowski CF. The pathology of hepatitis C as a function of mode of transmission: blood transfusion vs. intravenous drug use. Hepatology 1993; 18: 13381343.
  • 17
    Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Bréchot C, Brouwer JT, et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994; 19: 13211324.
  • 18
    Pawlotsky J–M, Tsakiris L, Roudot–Thoraval F, Pellet C, Stuyver L, Duval J, Dhumeaux D. Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis 1995; 171: 16071610.
  • 19
    Simmonds P, Mellor J, Craxi A, Sanchez–Tapias J–M, Alberti A, Prieto J, Colombo M, et al. Epidemic logical, clinical and therapeutic associations of hepatitis C types in western European patients. J Hepatol 1996; 24: 517524.
  • 20
    Zeuzem S, Teuber G, Lee J–H, Rkster B, Roth WK. Risk factors for the transmission of hepatitis C. J Hepatol 1996; 24 (suppl 2): 310.
  • 21
    Nousbaum JB, Pol S, Nalpas B, Landais P, Berthelot P, Brechot C and the Collaborative Study Group. Hepatitis C virus type Ib (II) infection in France and Italy. Ann Intern Med 1995; 122: 161168.
  • 22
    Dusheiko G, Schmilovitz–Weiss H, Brown D, McOmish F, Yap P–L, Sherlock S, McLntyre N, et al. Hepatitis C virus genotypes: an investigation of type–specific differences in geographic origin and disease. Hepatology 1994; 19: 1318.
  • 23
    Kobayashi M, Tanaka E, Sodeyama T, Urushihara A, Matsumoto A, Kiyosawa K. The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses. Hepatology 1996; 23: 695699.
  • 24
    Silini E, Bottelli R, Asti M, Bruno S, Candusso M–E, Brambilla S, Bono F, et al. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case–control study. Gastroenterology 1996; 111: 199205.
  • 25
    Féray C, Gigou M, Samuel D, Paradis V, Mishiro S, Maertens G, Reynés M, et al. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology 1995; 108: 10891097.
  • 26
    Yamada M, Kakumu S, Yoshioka K, Higashi Y, Tanaka K, Ishikawa T, Takayanagi M. Hepatitis C virus genotypes are not responsible for development of serious liver disease. Dig Dis Sci 1994; 39: 234239.
  • 27
    Mita E, Hayashi N, Kanazawa Y, Hagiwara H, Ueda K, Kasahara A, Fusamoto H, et al. Hepatitis C virus genotype and RNA titer in the progression of type C chronic liver disease. J Hepatol 1994; 21: 468473.
  • 28
    Kelen GD, Green GB, Purcell RH, Chan DW, Qaqish BF, Sivertson KT, Quinn TC. Hepatitis B and hepatitis C in emergency departments patients. N EnglJ Med 1992; 326: 13991404.
  • 29
    Lieber CS. Alcohol and the liver: 1984 update. Hepatology 1984; 6: 12431260.
  • 30
    Ikeda K, Saitoh S, Koida I, Arase Y, Tsubota A, Chayama K, Kumada H, et al. A multivariate analysis of risk factors for hepatocellular carcino–genesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 1993; 18: 4753.
  • 31
    Poynard T, Aubert A, Lazizi Y, Bedossa P, Hamelin B, Terris B, Naveau S, et al. Independent risk factors for hepatocellular carcinoma in French drinkers. Hepatology 1991; 13: 896901.
  • 32
    Deny P, Halimi C, Trinchet JC, Munz C, Bianchi A, Mai F, Beaugrand M. Rôle du virus de l' hépatite C dans la genèse des lésions hépatiques observées chez des malades alcooliques atteints de cirrhose. Gastroen–terol Clin Biol 1994; 18: 110114.
  • 33
    Oshita M, Hayashi N, Kasahara A, Hagiwara H, Mita E, Naito M, Kata–yama K, et al. Increased serum hepatitis C virus RNA levels among alcoholic patients with chronic hepatitis C. Hepatology 1994; 20: 11151120.
  • 34
    Brallet M–P, Roudot–Thoraval F, Pawlotsky J–M, Bastie A, Van Nhieu J Tran, Duval J, Dhumeaux D, et al. Histopathological impact of hepatitis G virus on chronic hepatitis C. Gastroenterology 1997; 112: 188192.